Howe Jill Ann Insider Trades

Insider Trading History

Track insider trading activity for Howe Jill Ann. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Lineage Cell Therapeutics
Lineage Cell Therapeutics LCTX
Chief Financial Officer
Holding Value $1.27M 1,050,000 shares
Last Trade
Mar 05, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.93M 1,050,000 shares
$1.84
$1.21
Lineage Cell Therapeutics
Lineage Cell Therapeutics LCTX
Chief Financial Officer
Holding Value $908k 750,000 shares
Last Trade
Mar 10, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$398k 750,000 shares
$0.53
$1.21
Lineage Cell Therapeutics
Lineage Cell Therapeutics LCTX
Chief Financial Officer
Holding Value $30.9k 25,500 shares
Last Trade
Nov 26, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$8.85k 15,000 shares
$0.59
$1.21
Lineage Cell Therapeutics
Lineage Cell Therapeutics LCTX
Chief Financial Officer
Holding Value $12.7k 10,500 shares
Last Trade
Aug 16, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$9.35k 10,500 shares
$0.89
$1.21
Lineage Cell Therapeutics
Lineage Cell Therapeutics LCTX
Chief Financial Officer
Holding Value $787k 650,000 shares
Last Trade
Mar 07, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$735k 650,000 shares
$1.13
$1.21
Lineage Cell Therapeutics
Lineage Cell Therapeutics LCTX
Chief Financial Officer
Holding Value $182k 150,000 shares
Last Trade
Mar 09, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$219k 150,000 shares
$1.46
$1.21
Lineage Cell Therapeutics
Lineage Cell Therapeutics LCTX
Chief Financial Officer
Holding Value $1.21M 1,000,000 shares
Last Trade
Nov 14, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.36M 1,000,000 shares
$1.36
$1.21

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up